RTP Global

RTP Global is an international early-stage venture firm with offices across the US, Europe, and India, investing in technology companies with a generalist mandate that spans consumer internet, B2B software, fintech, and selectively health technology. Stage focus is seed and Series A, with checks typically in the $2M to $8M range and the capacity to lead or co-lead. Healthcare exposure is opportunistic and concentrated in software-shape companies with strong commercial momentum rather than therapeutics or devices. Physician founders building consumer health platforms, telehealth, digital health software, or marketplaces with multi-geography expansion potential are the most credible fit. Founders building therapeutics, consumer wellness, or pure deep-tech regulated businesses should pitch elsewhere. Geographic posture is genuinely global, with active deal capacity in Europe, North America, and India. The realistic entry path is a warm introduction from a portfolio CEO, a co-investing seed fund, or an international ecosystem operator in the partner’s network; the firm is receptive to thesis-aligned cold outreach but referred deals receive faster diligence. Founders should arrive with traction signal, defended unit economics, and a credible international expansion narrative. Treat RTP Global as a serious international generalist partner with the geographic reach to support cross-border health technology companies, particularly those with Indian or European center of gravity, and a credible Series A lead for software-shape healthcare businesses.